Full Year 2024 Results Key Financial Results Revenue: US$212.5m (up 39% from FY 2023). Net ...

H.C. Wainwright analyst Yi Chen raised the firm’s price target on LifeMD (LFMD) to $14 from $12 and keeps a Buy rating on the shares. The ...

Teladoc Health is offering fertility, digestive health, and specialty care to its enterprise customers, the company said ...

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on LifeMD (LFMD – Research Report), with a price target of ...